期刊
INTERNATIONAL JOURNAL OF ONCOLOGY
卷 50, 期 6, 页码 2136-2144出版社
SPANDIDOS PUBL LTD
DOI: 10.3892/ijo.2017.3975
关键词
indoleamine 2,3-dioxygenase-1; lung cancer; angiogenesis; siRNA
类别
资金
- Natural Science Foundation of China (NSFC) [81673009]
- Jiangxi Science and Technology Innovation Programs [20124ACB00800]
- Canadian Institute of Health Research (CIHR)
The significance of indoleamine 2,3-dioxygenase-1 (IDOL) has been studied in various types of tumors, but the relationship between IDOL and tumor angiogenesis needs further delineation. We aimed to clarify the relationship between tumor angiogenesis and IDO1 expression, and to explore the possibility of IDOL-targeting molecular therapy for lung cancer. For the first time, we found that silencing the IDO1 gene using small interfering RNA (siRNA) inhibits in vitro cancer cell invasion and migration. We further demonstrated that knockdown of IDOL decreased the formation of vasculogenic mimicry. In addition to these in vitro findings, we also demonstrated that in vivo IDOL gene silencing using short hairpin RNA (shRNA) delayed tumor onset and inhibited tumor growth in the mouse model. Immunostaining showed that IDOL gene silencing inhibited tumor angiogenesis. Moreover, the expression of IDOL was associated with microvessel density (MVD) labeled by CD34 and CD146. These findings indicate that IDO1 has the potential to participate in or contribute to the formation of new capillaries, supporting the applicability of IDOL-targeting molecular therapy in lung cancer.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据